403 related articles for article (PubMed ID: 16142689)
1. Investigation of protein oxidation and lipid peroxidation in patients with rheumatoid arthritis.
Baskol G; Demir H; Baskol M; Kilic E; Ates F; Karakukcu C; Ustdal M
Cell Biochem Funct; 2006; 24(4):307-11. PubMed ID: 16142689
[TBL] [Abstract][Full Text] [Related]
2. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
[TBL] [Abstract][Full Text] [Related]
3. Protein oxidation status in patients with ankylosing spondylitis.
Yazici C; Köse K; Calis M; Kuzugüden S; Kirnap M
Rheumatology (Oxford); 2004 Oct; 43(10):1235-9. PubMed ID: 15292529
[TBL] [Abstract][Full Text] [Related]
4. Assessment of paraoxonase 1 activity and malondialdehyde levels in patients with rheumatoid arthritis.
Baskol G; Demir H; Baskol M; Kilic E; Ates F; Kocer D; Muhtaroglu S
Clin Biochem; 2005 Oct; 38(10):951-5. PubMed ID: 16055108
[TBL] [Abstract][Full Text] [Related]
5. [Determination of oxidation-reduction level in patients with rheumatoid arthritis].
Cai WC; Wang H; Li RQ; Gao L
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):749-50. PubMed ID: 15958331
[TBL] [Abstract][Full Text] [Related]
6. Lipid, protein, DNA oxidation and antioxidant status in rheumatoid arthritis.
Seven A; Güzel S; Aslan M; Hamuryudan V
Clin Biochem; 2008 May; 41(7-8):538-43. PubMed ID: 18313405
[TBL] [Abstract][Full Text] [Related]
7. Assessment of nitric oxide, advanced oxidation protein products, malondialdehyde, and thiol levels in patients with restless legs syndrome.
Baskol G; Korkmaz S; Erdem F; Caniklioglu A; Kocyigit M; Aksu M
Sleep Med; 2012 Apr; 13(4):414-8. PubMed ID: 22469072
[TBL] [Abstract][Full Text] [Related]
8. Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis.
Sarban S; Kocyigit A; Yazar M; Isikan UE
Clin Biochem; 2005 Nov; 38(11):981-6. PubMed ID: 16150434
[TBL] [Abstract][Full Text] [Related]
9. The importance of oxidative stress in patients with chronic renal failure whose hypertension is treated with peritoneal dialysis.
Demirci S; Sekeroğlu MR; Noyan T; Köçeroğlu R; Soyoral YU; Dülger H; Erkoç R
Cell Biochem Funct; 2011 Apr; 29(3):249-54. PubMed ID: 21465497
[TBL] [Abstract][Full Text] [Related]
10. Advanced oxidation protein products: a novel marker of oxidative stress in ulcerative colitis.
Baskol M; Baskol G; Koçer D; Ozbakir O; Yucesoy M
J Clin Gastroenterol; 2008 Jul; 42(6):687-91. PubMed ID: 18574392
[TBL] [Abstract][Full Text] [Related]
11. Gender difference as regards myocardial protein oxidation in aged rats: male rats have increased oxidative protein damage.
Kayali R; Cakatay U; Uzun H; Genç H
Biogerontology; 2007 Dec; 8(6):653-61. PubMed ID: 17846913
[TBL] [Abstract][Full Text] [Related]
12. Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism.
Torun AN; Kulaksizoglu S; Kulaksizoglu M; Pamuk BO; Isbilen E; Tutuncu NB
Clin Endocrinol (Oxf); 2009 Mar; 70(3):469-74. PubMed ID: 18727709
[TBL] [Abstract][Full Text] [Related]
13. Protein thiol oxidation and lipid peroxidation in patients with uraemia.
Prakash M; Upadhya S; Prabhu R
Scand J Clin Lab Invest; 2004; 64(6):599-604. PubMed ID: 15370466
[TBL] [Abstract][Full Text] [Related]
14. Serum advanced oxidation protein products, myeloperoxidase and ascorbic acid in pre-eclampsia and eclampsia.
Noyan T; Güler A; Sekeroğlu MR; Kamaci M
Aust N Z J Obstet Gynaecol; 2006 Dec; 46(6):486-91. PubMed ID: 17116052
[TBL] [Abstract][Full Text] [Related]
15. Evidence for immune activation against oxidized lipoproteins in inactive phases of juvenile chronic arthritis.
Simonini G; Matucci Cerinic M; Cimaz R; Anichini M; Cesaretti S; Zoppi M; Generini S; Falcini F
J Rheumatol; 2001 Jan; 28(1):198-203. PubMed ID: 11196525
[TBL] [Abstract][Full Text] [Related]
16. Does renal function influence plasma levels of advanced glycation and oxidation protein products in patients with chronic rheumatic diseases complicated by secondary amyloidosis?
Rysavá R; Kalousová M; Zima T; Dostál C; Merta M; Tesar V
Kidney Blood Press Res; 2007; 30(1):1-7. PubMed ID: 17191033
[TBL] [Abstract][Full Text] [Related]
17. Advanced oxidation protein products, ferrous oxidation in xylenol orange, and malondialdehyde levels in thyroid cancer.
Kosova F; Cetin B; Akinci M; Aslan S; Ari Z; Sepici A; Altan N; çetin A
Ann Surg Oncol; 2007 Sep; 14(9):2616-20. PubMed ID: 17564752
[TBL] [Abstract][Full Text] [Related]
18. The change of oxidative stress products in diabetes mellitus and diabetic retinopathy.
Pan HZ; Zhang H; Chang D; Li H; Sui H
Br J Ophthalmol; 2008 Apr; 92(4):548-51. PubMed ID: 18369071
[TBL] [Abstract][Full Text] [Related]
19. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus.
Morgan PE; Sturgess AD; Davies MJ
Arthritis Rheum; 2005 Jul; 52(7):2069-79. PubMed ID: 15986354
[TBL] [Abstract][Full Text] [Related]
20. Levels of paraoxonase, an index of antioxidant defense, in patients with active sarcoidosis.
Uzun H; Yanardag H; Gelisgen R; Genc H; Uygun S; Vehid S; Karter Y; Demirci S
Curr Med Res Opin; 2008 Jun; 24(6):1651-7. PubMed ID: 18474147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
